{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T13:38:57Z","timestamp":1778074737251,"version":"3.51.4"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"9-10","license":[{"start":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T00:00:00Z","timestamp":1606953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T00:00:00Z","timestamp":1606953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005788","name":"Medical University of Vienna","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005788","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:title>Summary<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Portal hypertension (PH) causes severe complications in patients with liver cirrhosis, such as variceal bleeding and ascites; however, data on the knowledge and perceptions on guideline recommendations for the management of varices and the use of albumin is scarce.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We designed two structured surveys on (i)\u00a0the management of varices and (ii)\u00a0the use of albumin for Austrian physicians of specialized Gastro-Intestinal (GI) centers. The interviewed physicians were confronted spontaneously and provided <jats:italic>ad hoc<\/jats:italic> responses to the questionnaire.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In total, 158 surveys were completed. Interestingly, many specialists (30%) would recommend a\u00a0follow-up gastroscopy after 1\u00a0year in patients with compensated cirrhosis without varices (i.e., overtreatment). For small varices, 81.5% would use non-selective beta blockers (NSBB) for primary prophylaxis (PP). For PP in patients with large varices, endoscopic band ligation (EBL) plus NSBB was preferred by 51.4% (i.e., overtreatment). Knowledge on the indication criteria for early TIPS (transjugular intrahepatic portosystemic shunt) was reported by 54.3%, but only 20% could report these criteria correctly. The majority (87.1%) correctly indicated a preference to use NSBB and EBL for secondary prophylaxis (SP).<\/jats:p>\n                <jats:p>The majority of participating gastroenterologists reported no restrictions on the use of albumin (89.8%) in their hospitals. Of the interviewed specialists, 63.6% would use albumin in patients with SBP; however, only 11.4% would use the doses recommended by guidelines. The majority of specialists indicated using albumin at the recommended doses for hepatorenal syndrome (HRS-AKI, 86.4%) and for large volume paracentesis (LVP, 73.3%). The individual responses regarding albumin use for infections\/sepsis, hyponatremia, renal impairment, and encephalopathy were heterogeneous.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The reported management of PH and varices is mostly adherent to guidelines, but endoscopic surveillance in patients without varices is too intense and EBL is overused in the setting of PP. Knowledge on the correct use of early TIPS must be improved among Austrian specialists. Albumin use is widely unrestricted in Austria; however, albumin is often underdosed in established indications.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00508-020-01769-9","type":"journal-article","created":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T15:04:08Z","timestamp":1607007848000},"page":"421-431","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Perceptions on the management of varices and on the use of albumin in patients with cirrhosis among GI specialists in Austria"],"prefix":"10.1007","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1336-7250","authenticated-orcid":false,"given":"Nikolaus","family":"Pfisterer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Schmidbauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Riedl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Maieron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Stadlbauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Hennlich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Remy","family":"Schwarzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Puespoek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresa","family":"Bucsics","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Effenberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Bota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Gschwantler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Peck-Radosavljevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mattias","family":"Mandorfer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Madl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Trauner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Reiberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,12,3]]},"reference":[{"key":"1769_CR1","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","volume":"63","author":"R de Franchis","year":"2015","unstructured":"de Franchis\u00a0R, Baveno VI Faculty. Expanding consensus in portal hypertension: report of the Baveno VI consensus workshop: stratifying risk and individualizing care for portal hypertension. J\u00a0Hepatol. 2015;63:743\u201352.","journal-title":"J Hepatol"},{"key":"1769_CR2","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00508-017-1262-3","volume":"129","author":"T Reiberger","year":"2017","unstructured":"Reiberger\u00a0T, P\u00fcsp\u00f6k\u00a0A, Schoder\u00a0M, et\u00a0al. Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth\u00a0III). Wien Klin Wochenschr. 2017;129:135\u201358.","journal-title":"Wien Klin Wochenschr"},{"key":"1769_CR3","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","volume":"69","author":"European Association for the Study of the Liver","year":"2018","unstructured":"European Association for the Study of the Liver. EASL clinical practice guidelines for the management of patients with decompensated cirrhosis. J\u00a0Hepatol. 2018;69:406\u201360.","journal-title":"J Hepatol"},{"key":"1769_CR4","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.cgh.2010.02.022","volume":"8","author":"J Moodley","year":"2010","unstructured":"Moodley\u00a0J, Lopez\u00a0R, Carey\u00a0W. Compliance with practice guidelines and risk of a\u00a0first esophageal variceal hemorrhage in patients with cirrhosis. Clin Gastroenterol Hepatol. 2010;8:703\u20138.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1769_CR5","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1177\/1062860614556089","volume":"31","author":"V Loy","year":"2016","unstructured":"Loy\u00a0V, Kwiatt\u00a0J, Dodda\u00a0A, Martin\u00a0E, Dua\u00a0A, Saeian\u00a0K. Performance feedback improves compliance with quality measures. Am J Med Qual. 2016;31:118\u201324.","journal-title":"Am J Med Qual"},{"key":"1769_CR6","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1097\/MEG.0000000000000548","volume":"28","author":"M Pericleous","year":"2016","unstructured":"Pericleous\u00a0M, Sarnowski\u00a0A, Moore\u00a0A, Fijten\u00a0R, Zaman\u00a0M. The clinical management of abdominal ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: a\u00a0review of current guidelines and recommendations. Eur J Gastroenterol Hepatol. 2016;28:e10\u20138.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1769_CR7","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJM198810133191505","volume":"319","author":"North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices","year":"1988","unstructured":"North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. N\u00a0Engl J Med. 1988;319:983\u20139.","journal-title":"N Engl J Med"},{"key":"1769_CR8","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1053\/jhep.2003.50385","volume":"38","author":"G D\u2019Amico","year":"2003","unstructured":"D\u2019Amico\u00a0G, De Franchis\u00a0R, Cooperative Study Group. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology. 2003;38:599\u2013612.","journal-title":"Hepatology"},{"key":"1769_CR9","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.dld.2013.12.010","volume":"46","author":"V Jairath","year":"2014","unstructured":"Jairath\u00a0V, Rehal\u00a0S, Logan\u00a0R, Kahan\u00a0B, Hearnshaw\u00a0S, Stanworth\u00a0S, et\u00a0al. Acute variceal haemorrhage in the United Kingdom: patient characteristics, management and outcomes in a\u00a0nationwide audit. Dig Liver Dis. 2014;46:419\u201326.","journal-title":"Dig Liver Dis"},{"key":"1769_CR10","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/MEG.0b013e3283510448","volume":"24","author":"RM Cerqueira","year":"2012","unstructured":"Cerqueira\u00a0RM, Andrade\u00a0L, Correia\u00a0MR, Fernandes\u00a0CD, Manso\u00a0MC. Risk factors for in-hospital mortality in cirrhotic patients with oesophageal variceal bleeding. Eur J Gastroenterol Hepatol. 2012;24:551\u20137.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1769_CR11","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/hep.21089","volume":"43","author":"K Stokkeland","year":"2006","unstructured":"Stokkeland\u00a0K, Brandt\u00a0L, Ekbom\u00a0A, Hultcrantz\u00a0R. Improved prognosis for patients hospitalized with esophageal varices in Sweden 1969\u20132002. Hepatology. 2006;43:500\u20135.","journal-title":"Hepatology"},{"key":"1769_CR12","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/0016-5085(81)90144-X","volume":"80","author":"DY Graham","year":"1981","unstructured":"Graham\u00a0DY, Smith\u00a0JL. The course of patients after variceal hemorrhage. Gastroenterology. 1981;80:800\u20139.","journal-title":"Gastroenterology"},{"key":"1769_CR13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2005.05.009","volume":"43","author":"R de Franchis","year":"2005","unstructured":"de Franchis\u00a0R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J\u00a0Hepatol. 2005;43:167\u201376.","journal-title":"J Hepatol"},{"key":"1769_CR14","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/apt.14485","volume":"47","author":"N Pfisterer","year":"2018","unstructured":"Pfisterer\u00a0N, Dexheimer\u00a0C, Fuchs\u00a0E\u2011M, et al. Betablockers do not increase efficacy of band ligation in primary prophylaxis but they improve survival in secondary prophylaxis of variceal bleeding. Aliment Pharmacol Ther. 2018;47:966\u201379.","journal-title":"Aliment Pharmacol Ther"},{"key":"1769_CR15","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1111\/apt.14581","volume":"47","author":"N Pfisterer","year":"2018","unstructured":"Pfisterer\u00a0N, Mandorfer\u00a0M, Reiberger\u00a0T. Editorial: use of beta-blockers and band ligation in preventing first and recurrent variceal bleeding-\u201creal life\u201d vs evidence-based decisions. Authors\u2019 reply. Aliment Pharmacol Ther. 2018;47:1224\u20135.","journal-title":"Aliment Pharmacol Ther"},{"key":"1769_CR16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jhep.2017.09.002","volume":"68","author":"D Thabut","year":"2017","unstructured":"Thabut\u00a0D, Pauwels\u00a0A, Carbonell\u00a0N, et al. Cirrhotic patients with portal hypertension-related bleeding and an indication for early-TIPS: a\u00a0large multicentre audit with real-life results. J\u00a0Hepatol. 2017;68:73\u201381.","journal-title":"J Hepatol"},{"key":"1769_CR17","doi-asserted-by":"crossref","first-page":"100122","DOI":"10.1016\/j.jhepr.2020.100122","volume":"2","author":"JC Garc\u00eda-Pag\u00e1n","year":"2020","unstructured":"Garc\u00eda-Pag\u00e1n\u00a0JC, Saffo\u00a0S, Mandorfer\u00a0M, Garcia-Tsao\u00a0G. Where does TIPS fit in the management of patients with cirrhosis? JHEP Rep. 2020;2:100122.","journal-title":"JHEP Rep"},{"key":"1769_CR18","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1136\/gutjnl-2011-301348","volume":"61","author":"A Krag","year":"2012","unstructured":"Krag\u00a0A, Wiest\u00a0R, Albillos\u00a0A, Gluud\u00a0LL. The window hypothesis: haemodynamic and non-haemodynamic effects of \u03b2\u2011blockers improve survival of patients with cirrhosis during a\u00a0window in the disease. Gut. 2012;61:967\u20139.","journal-title":"Gut"},{"key":"1769_CR19","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1136\/gutjnl-2014-308424","volume":"64","author":"A Krag","year":"2015","unstructured":"Krag\u00a0A, Madsen\u00a0BS. To block, or not to block in advanced cirrhosis and ascites: that is the question. Gut. 2015;64:1015\u20137.","journal-title":"Gut"},{"key":"1769_CR20","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1136\/gutjnl-2013-306502","volume":"64","author":"JA Leithead","year":"2015","unstructured":"Leithead\u00a0JA, Rajoriya\u00a0N, Tehami\u00a0N, Hodson\u00a0J, Gunson\u00a0BK, Tripathi\u00a0D, et al. Non-selective \u03b2\u2011blockers are associated with improved survival in patients with ascites listed for liver transplantation. Gut. 2015;64:1111\u20139.","journal-title":"Gut"},{"key":"1769_CR21","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1053\/j.gastro.2014.03.005","volume":"146","author":"M Mandorfer","year":"2014","unstructured":"Mandorfer\u00a0M, Bota\u00a0S, Schwabl\u00a0P, et\u00a0al. Nonselective \u03b2 blockers increase risk for hepatorenal syndrome and death in patients with cirrhosis and spontaneous bacterial peritonitis. Gastroenterology. 2014;146:1680\u20131690.e1.","journal-title":"Gastroenterology"},{"key":"1769_CR22","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/hep.26359","volume":"57","author":"BA Runyon","year":"2013","unstructured":"Runyon\u00a0BA, AASLD. Introduction to the revised American association for the study of liver diseases practice guideline management of adult patients with ascites due to cirrhosis 2012. Hepatology. 2013;57:1651\u20133.","journal-title":"Hepatology"},{"key":"1769_CR23","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/hep.28906","volume":"65","author":"G Garcia-Tsao","year":"2017","unstructured":"Garcia-Tsao\u00a0G, Abraldes\u00a0JG, Berzigotti\u00a0A, Bosch\u00a0J. Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American association for the study of liver diseases. Hepatology. 2017;65:310\u201335.","journal-title":"Hepatology"},{"key":"1769_CR24","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1016\/S0140-6736(18)30840-7","volume":"391","author":"P Caraceni","year":"2018","unstructured":"Caraceni\u00a0P, Riggio\u00a0O, Angeli\u00a0P, et al. Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial. Lancet. 2018;391:2417\u201329.","journal-title":"Lancet"},{"key":"1769_CR25","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/liv.12528","volume":"35","author":"R Garcia-Martinez","year":"2015","unstructured":"Garcia-Martinez\u00a0R, Noiret\u00a0L, Sen\u00a0S, Mookerjee\u00a0R, Jalan\u00a0R. Albumin infusion improves renal blood flow autoregulation in patients with acute decompensation of cirrhosis and acute kidney injury. Liver Int. 2015;35:335\u201343.","journal-title":"Liver Int"},{"key":"1769_CR26","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.26338","volume":"58","author":"R Garcia-Martinez","year":"2013","unstructured":"Garcia-Martinez\u00a0R, Caraceni\u00a0P, Bernardi\u00a0M, Gines\u00a0P, Arroyo\u00a0V, Jalan\u00a0R. Albumin: pathophysiologic basis of its role in the treatment of cirrhosis and its complications. Hepatology. 2013;58:1836\u201346.","journal-title":"Hepatology"},{"key":"1769_CR27","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1053\/j.gastro.2008.02.024","volume":"134","author":"M Mart\u00edn-Llah\u00ed","year":"2008","unstructured":"Mart\u00edn-Llah\u00ed\u00a0M, P\u00e9pin\u00a0M\u2011N, Guevara\u00a0M, et al. Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a\u00a0randomized study. Gastroenterology. 2008;134:1352\u20139.","journal-title":"Gastroenterology"},{"key":"1769_CR28","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.jhep.2012.06.013","volume":"57","author":"M Guevara","year":"2012","unstructured":"Guevara\u00a0M, Terra\u00a0C, Nazar\u00a0A, Sol\u00e0\u00a0E, Fern\u00e1ndez\u00a0J, Pavesi\u00a0M, et\u00a0al. Albumin for bacterial infections other than spontaneous bacterial peritonitis in cirrhosis. A randomized, controlled study. J\u00a0Hepatol. 2012;57:759\u201365.","journal-title":"J Hepatol"},{"key":"1769_CR29","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1053\/j.gastro.2019.03.021","volume":"157","author":"J Fern\u00e1ndez","year":"2019","unstructured":"Fern\u00e1ndez\u00a0J, Cl\u00e0ria\u00a0J, Amor\u00f3s\u00a0A, et\u00a0al. Effects of albumin treatment on systemic and portal hemodynamics and systemic inflammation in patients with decompensated cirrhosis. Gastroenterology. 2019;157:149\u201362.","journal-title":"Gastroenterology"},{"key":"1769_CR30","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1056\/NEJMoa040232","volume":"350","author":"S Finfer","year":"2004","unstructured":"Finfer\u00a0S, Bellomo\u00a0R, Boyce\u00a0N, French\u00a0J, Myburgh\u00a0J, Norton\u00a0R, et\u00a0al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N\u00a0Engl J Med. 2004;350:2247\u201356.","journal-title":"N Engl J Med"},{"key":"1769_CR31","unstructured":"Statistik Austria. Volksz\u00e4hlungen, Registerz\u00e4hlung, Abgestimmte Erwerbsstatistik. 2020. http:\/\/www.statistik.at\/web_de\/statistiken\/menschen_und_gesellschaft\/bevoelkerung\/volkszaehlungen_registerzaehlungen_abgestimmte_erwerbsstatistik\/index.html. Accessed 25 Oct 2020."},{"key":"1769_CR32","unstructured":"Statistik Austria. Gliederungen nach st\u00e4dtischen und l\u00e4ndlichen Gebieten. 2020. https:\/\/www.statistik.at\/web_de\/klassifikationen\/regionale_gliederungen\/stadt_land\/index.html. Accessed 25 Oct 2020."},{"key":"1769_CR33","doi-asserted-by":"crossref","first-page":"e0189414","DOI":"10.1371\/journal.pone.0189414","volume":"13","author":"T Bucsics","year":"2018","unstructured":"Bucsics\u00a0T, Schoder\u00a0M, Diermayr\u00a0M, et al. Transjugular intrahepatic portosystemic shunts (TIPS) for the prevention of variceal re-bleeding\u2014a two decades experience. PLoS ONE. 2018;13:e189414.","journal-title":"PLoS ONE"},{"key":"1769_CR34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00365521.2017.1329456","volume":"52","author":"B Scheiner","year":"2017","unstructured":"Scheiner\u00a0B, Parada-Rodriguez\u00a0D, Bucsics\u00a0T, et al. Non-selective beta-blocker treatment does not impact on kidney function in cirrhotic patients with varices. Scand J Gastroenterol. 2017;52:1\u20138.","journal-title":"Scand J Gastroenterol"},{"key":"1769_CR35","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jhep.2016.11.001","volume":"66","author":"T Reiberger","year":"2017","unstructured":"Reiberger\u00a0T, Mandorfer\u00a0M. Beta adrenergic blockade and decompensated cirrhosis. J\u00a0Hepatol. 2017;66:849\u201359.","journal-title":"J Hepatol"},{"key":"1769_CR36","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/apt.14576","volume":"47","author":"R Schwarzer","year":"2018","unstructured":"Schwarzer\u00a0R, Kivaranovic\u00a0D, Paternostro\u00a0R, Mandorfer\u00a0M, Reiberger\u00a0T, Trauner\u00a0M, et al. Carvedilol for reducing portal pressure in primary prophylaxis of variceal bleeding: a\u00a0dose-response study. Aliment Pharmacol Ther. 2018;47:1162\u20139.","journal-title":"Aliment Pharmacol Ther"},{"key":"1769_CR37","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1136\/gutjnl-2016-311573","volume":"65","author":"KH Thorhauge","year":"2016","unstructured":"Thorhauge\u00a0KH, Lindvig\u00a0KP, Laleman\u00a0W, Angeli\u00a0P, Singh\u00a0SP, Krag\u00a0A. Lack of consensus for usage of \u03b2\u2011blockers in end-stage liver disease. Gut. 2016;65:1058\u201360.","journal-title":"Gut"},{"key":"1769_CR38","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1155\/2006\/203217","volume":"20","author":"J Cheung","year":"2006","unstructured":"Cheung\u00a0J, Wong\u00a0W, Zandieh\u00a0I, Leung\u00a0Y, Lee\u00a0SS, Ramji\u00a0A, et\u00a0al. Acute management and secondary prophylaxis of esophageal variceal bleeding: a\u00a0western Canadian survey. Can J Gastroenterol. 2006;20:531\u20134.","journal-title":"Can J Gastroenterol"},{"key":"1769_CR39","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.dld.2016.09.013","volume":"49","author":"M Mandorfer","year":"2017","unstructured":"Mandorfer\u00a0M, Reiberger\u00a0T. Beta blockers and cirrhosis, 2016. Dig Liver Dis. 2017;49:3\u201310.","journal-title":"Dig Liver Dis"},{"key":"1769_CR40","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s12072-012-9353-8","volume":"7","author":"SK Sarin","year":"2013","unstructured":"Sarin\u00a0SK, Mishra\u00a0SR, Sharma\u00a0P, Sharma\u00a0BC, Kumar\u00a0A. Early primary prophylaxis with beta-blockers does not prevent the growth of small esophageal varices in cirrhosis: a\u00a0randomized controlled trial. Hepatol Int. 2013;7:248\u201356.","journal-title":"Hepatol Int"},{"key":"1769_CR41","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1136\/gutjnl-2016-312814","volume":"66","author":"M Mandorfer","year":"2017","unstructured":"Mandorfer\u00a0M, Peck-Radosavljevic\u00a0M, Reiberger\u00a0T. Prevention of progression from small to large varices: are we there yet? An updated meta-analysis. Gut. 2017;66:1347\u20139.","journal-title":"Gut"},{"key":"1769_CR42","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/S0140-6736(18)31875-0","volume":"393","author":"C Villanueva","year":"2019","unstructured":"Villanueva\u00a0C, Albillos\u00a0A, Genesc\u00e0\u00a0J, et al. \u03b2 blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a\u00a0randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2019;393:1597\u2013608.","journal-title":"Lancet"},{"key":"1769_CR43","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jhep.2012.12.011","volume":"58","author":"T Reiberger","year":"2013","unstructured":"Reiberger\u00a0T, Ferlitsch\u00a0A, Payer\u00a0BA, et al. Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL\u20116 in patients with cirrhosis. J\u00a0Hepatol. 2013;58:911\u201321.","journal-title":"J Hepatol"},{"key":"1769_CR44","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1097\/MEG.0000000000000387","volume":"27","author":"M Sinclair","year":"2015","unstructured":"Sinclair\u00a0M, Vaughan\u00a0R, Angus\u00a0PW, Gow\u00a0PJ, Parker\u00a0F, Hey\u00a0P, et al. Risk factors for band-induced ulcer bleeding after prophylactic and therapeutic endoscopic variceal band ligation. Eur J Gastroenterol Hepatol. 2015;27:928\u201332.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1769_CR45","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1572-0241.2005.40468.x","volume":"100","author":"SK Sarin","year":"2005","unstructured":"Sarin\u00a0SK, Wadhawan\u00a0M, Agarwal\u00a0SR, Tyagi\u00a0P, Sharma\u00a0BC. Endoscopic variceal ligation plus propranolol versus endoscopic variceal ligation alone in primary prophylaxis of variceal bleeding. Am J Gastroenterol. 2005;100:797\u2013804.","journal-title":"Am J Gastroenterol"},{"key":"1769_CR46","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/hep.23617","volume":"52","author":"G-H Lo","year":"2010","unstructured":"Lo\u00a0G\u2011H, Chen\u00a0W\u2011C, Wang\u00a0H\u2011M, Lee\u00a0C\u2011C. Controlled trial of ligation plus nadolol versus nadolol alone for the prevention of first variceal bleeding. Hepatology. 2010;52:230\u20137.","journal-title":"Hepatology"},{"key":"1769_CR47","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1136\/gutjnl-2012-304038","volume":"62","author":"T Reiberger","year":"2013","unstructured":"Reiberger\u00a0T, Ulbrich\u00a0G, Ferlitsch\u00a0A, et al. Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol. Gut. 2013;62:1634\u201341.","journal-title":"Gut"},{"key":"1769_CR48","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1708806","author":"M Mandorfer","year":"2020","unstructured":"Mandorfer\u00a0M, Hern\u00e1ndez-Gea\u00a0V, Garc\u00eda-Pag\u00e1n\u00a0JC, Reiberger\u00a0T. Noninvasive diagnostics for portal hypertension: a comprehensive review. Semin Liver Dis. 2020; https:\/\/doi.org\/10.1055\/s-0040-1708806.","journal-title":"Semin Liver Dis"},{"key":"1769_CR49","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00508-012-0190-5","volume":"124","author":"T Reiberger","year":"2012","unstructured":"Reiberger\u00a0T, Ferlitsch\u00a0A, Payer\u00a0BA, Pinter\u00a0M, Schwabl\u00a0P, Stift\u00a0J, et\u00a0al. Noninvasive screening for liver fibrosis and portal hypertension by transient elastography\u2014a large single center experience. Wien Klin Wochenschr. 2012;124:395\u2013402.","journal-title":"Wien Klin Wochenschr"},{"key":"1769_CR50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00508-019-01593-w","volume":"132","author":"B Simbrunner","year":"2020","unstructured":"Simbrunner\u00a0B, Beer\u00a0A, W\u00f6ran\u00a0K, et\u00a0al. Portal hypertensive gastropathy is associated with iron deficiency anemia. Wien Klin Wochenschr. 2020;132:1\u201311.","journal-title":"Wien Klin Wochenschr"},{"key":"1769_CR51","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/liv.14229","volume":"40","author":"B Scheiner","year":"2020","unstructured":"Scheiner\u00a0B, Semmler\u00a0G, Maurer\u00a0F, et\u00a0al. Prevalence of and risk factors for anaemia in patients with advanced chronic liver disease. Liver Int. 2020;40:194\u2013204.","journal-title":"Liver Int"},{"key":"1769_CR52","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.dld.2010.10.006","volume":"43","author":"C Ripoll","year":"2011","unstructured":"Ripoll\u00a0C, Garcia-Tsao\u00a0G. The management of portal hypertensive gastropathy and gastric antral vascular ectasia. Dig Liver Dis. 2011;43:345\u201351.","journal-title":"Dig Liver Dis"},{"key":"1769_CR53","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jhep.2016.05.027","volume":"65","author":"M Mandorfer","year":"2016","unstructured":"Mandorfer\u00a0M, Kozbial\u00a0K, Schwabl\u00a0P, et al. Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension. J\u00a0Hepatol. 2016;65:692\u20139.","journal-title":"J Hepatol"},{"key":"1769_CR54","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/apt.13844","volume":"45","author":"P Schwabl","year":"2017","unstructured":"Schwabl\u00a0P, Mandorfer\u00a0M, Steiner\u00a0S, et al. Interferon-free regimens improve portal hypertension and histological necroinflammation in HIV\/HCV patients with advanced liver disease. Aliment Pharmacol Ther. 2017;45:139\u201349.","journal-title":"Aliment Pharmacol Ther"},{"key":"1769_CR55","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jhep.2019.10.002","volume":"72","author":"V Giannelli","year":"2020","unstructured":"Giannelli\u00a0V, Roux\u00a0O, Laou\u00e9nan\u00a0C, et\u00a0al. Impact of cardiac function, refractory ascites and beta blockers on the outcome of patients with cirrhosis listed for liver transplantation. J\u00a0Hepatol. 2020;72:463\u201371.","journal-title":"J Hepatol"},{"key":"1769_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.03.048","author":"E Alvarado-Tapias","year":"2020","unstructured":"Alvarado-Tapias\u00a0E, Ardevol\u00a0A, Garcia-Guix\u00a0M, et al. Short-term hemodynamic effects of \u03b2\u2011blockers influence survival of patients with decompensated cirrhosis. J\u00a0Hepatol. 2020; https:\/\/doi.org\/10.1016\/j.jhep.2020.03.048.","journal-title":"J Hepatol"},{"key":"1769_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.05.011","author":"L T\u00e9llez","year":"2020","unstructured":"T\u00e9llez\u00a0L, Ib\u00e1\u00f1ez-Samaniego\u00a0L, P\u00e9rez Del Villar\u00a0C, et al. Non-selective beta-blockers impair global circulatory homeostasis and renal function in cirrhotic patients with refractory ascites. J\u00a0Hepatol. 2020; https:\/\/doi.org\/10.1016\/j.jhep.2020.05.011.","journal-title":"J Hepatol"},{"key":"1769_CR58","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/apt.15439","volume":"50","author":"TL Tergast","year":"2019","unstructured":"Tergast\u00a0TL, Kimmann\u00a0M, Laser\u00a0H, Gerbel\u00a0S, Manns\u00a0MP, Cornberg\u00a0M, et al. Systemic arterial blood pressure determines the therapeutic window of non-selective beta blockers in decompensated cirrhosis. Aliment Pharmacol Ther. 2019;50:696\u2013706.","journal-title":"Aliment Pharmacol Ther"},{"key":"1769_CR59","first-page":"S694","volume":"68","author":"T Bucsics","year":"2018","unstructured":"Bucsics\u00a0T, Schoder\u00a0M, Mandorfer\u00a0M, et\u00a0al. Effectiveness of \u201cearly\u201d TIPS implantation versus \u201clate\u201d TIPS versus standard endoscopic treatment for acute variceal bleeding in patients with liver cirrhosis. J\u00a0Hepatol. 2018;68:S694\u2013S5.","journal-title":"J Hepatol"},{"key":"1769_CR60","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1056\/NEJMoa0910102","volume":"362","author":"JC Garc\u00eda-Pag\u00e1n","year":"2010","unstructured":"Garc\u00eda-Pag\u00e1n\u00a0JC, Caca\u00a0K, Bureau\u00a0C, et al. Early use of TIPS in patients with cirrhosis and variceal bleeding. N\u00a0Engl J Med. 2010;362:2370\u20139.","journal-title":"N Engl J Med"},{"key":"1769_CR61","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.dld.2017.08.002","volume":"49","author":"T Bucsics","year":"2017","unstructured":"Bucsics\u00a0T, Schoder\u00a0M, Goeschl\u00a0N, et al. Re-bleeding rates and survival after early transjugular intrahepatic portosystemic shunt (TIPS) in clinical practice. Dig Liver Dis. 2017;49:1360\u20137.","journal-title":"Dig Liver Dis"},{"key":"1769_CR62","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/liv.13971","volume":"39","author":"N Pfisterer","year":"2019","unstructured":"Pfisterer\u00a0N, Riedl\u00a0F, Pachofszky\u00a0T, et al. Outcomes after placement of a\u00a0SX-ELLA oesophageal stent for refractory variceal bleeding\u2014a national multicentre study. Liver Int. 2019;39:290\u20138.","journal-title":"Liver Int"},{"key":"1769_CR63","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/hep.30287","volume":"69","author":"V Hern\u00e1ndez-Gea","year":"2019","unstructured":"Hern\u00e1ndez-Gea\u00a0V, Procopet\u00a0B, Gir\u00e1ldez \u00c1, et al. Preemptive-TIPS improves outcome in high-risk variceal bleeding: an observational study. Hepatology. 2019;69:282\u201393.","journal-title":"Hepatology"},{"key":"1769_CR64","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.23775","volume":"52","author":"T Serst\u00e9","year":"2010","unstructured":"Serst\u00e9\u00a0T, Melot\u00a0C, Francoz\u00a0C, Durand\u00a0F, Rautou\u00a0P\u2011E, Valla\u00a0D, et al. Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites. Hepatology. 2010;52:1017\u201322.","journal-title":"Hepatology"},{"key":"1769_CR65","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jhep.2017.02.005","volume":"67","author":"R Sinha","year":"2017","unstructured":"Sinha\u00a0R, Lockman\u00a0KA, Mallawaarachchi\u00a0N, Robertson\u00a0M, Plevris\u00a0JN, Hayes\u00a0PC. Carvedilol use is associated with improved survival in patients with liver cirrhosis and ascites. J\u00a0Hepatol. 2017;67:40\u20136.","journal-title":"J Hepatol"},{"key":"1769_CR66","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1136\/gutjnl-2016-311527","volume":"65","author":"GN Kalambokis","year":"2016","unstructured":"Kalambokis\u00a0GN, Baltayiannis\u00a0G, Christou\u00a0L, Christodoulou\u00a0D. Red signs and not severity of cirrhosis should determine non-selective \u03b2\u2011blocker treatment in Child-Pugh C cirrhosis with small varices: increased risk of hepatorenal syndrome and death beyond 6\u00a0months of propranolol use. Gut. 2016;65:1228\u201330.","journal-title":"Gut"},{"key":"1769_CR67","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1136\/gutjnl-2016-312129","volume":"65","author":"B Njei","year":"2016","unstructured":"Njei\u00a0B, McCarty\u00a0TR, Garcia-Tsao\u00a0G. Beta-blockers in patients with cirrhosis and ascites: type of beta-blocker matters. Gut. 2016;65:1393\u20134.","journal-title":"Gut"},{"key":"1769_CR68","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jhep.2015.10.018","volume":"64","author":"RP Mookerjee","year":"2016","unstructured":"Mookerjee\u00a0RP, Pavesi\u00a0M, Thomsen\u00a0KL, et al. Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic liver failure. J\u00a0Hepatol. 2016;64:574\u201382.","journal-title":"J Hepatol"},{"key":"1769_CR69","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1097\/MCG.0000000000000735","volume":"51","author":"A Garioud","year":"2017","unstructured":"Garioud\u00a0A, Cadranel\u00a0J\u2011F, Pauwels\u00a0A, et al. Albumin use in patients with cirrhosis in France: results of the \u201cALBU-LIVE\u201d survey: a case for better EASL guidelines diffusion and\/or revision. J\u00a0Clin Gastroenterol. 2017;51:831\u20138.","journal-title":"J Clin Gastroenterol"},{"key":"1769_CR70","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s12072-015-9665-6","volume":"10","author":"R Spinella","year":"2016","unstructured":"Spinella\u00a0R, Sawhney\u00a0R, Jalan\u00a0R. Albumin in chronic liver disease: structure, functions and therapeutic implications. Hepatol Int. 2016;10:124\u201332.","journal-title":"Hepatol Int"},{"key":"1769_CR71","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.jhep.2015.07.004","volume":"63","author":"M Bernardi","year":"2015","unstructured":"Bernardi\u00a0M, Moreau\u00a0R, Angeli\u00a0P, Schnabl\u00a0B, Arroyo\u00a0V. Mechanisms of decompensation and organ failure in cirrhosis: from peripheral arterial vasodilation to systemic inflammation hypothesis. J\u00a0Hepatol. 2015;63:1272\u201384.","journal-title":"J Hepatol"},{"key":"1769_CR72","doi-asserted-by":"crossref","first-page":"7674","DOI":"10.1073\/pnas.89.16.7674","volume":"89","author":"JS Stamler","year":"1992","unstructured":"Stamler\u00a0JS, Jaraki\u00a0O, Osborne\u00a0J, Simon\u00a0DI, Keaney\u00a0J, Vita\u00a0J, et al. Nitric oxide circulates in mammalian plasma primarily as an S\u2011nitroso adduct of serum albumin. Proc Natl Acad Sci U S\u00a0A. 1992;89:7674\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1769_CR73","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nm.3516","volume":"20","author":"AJ O\u2019Brien","year":"2014","unstructured":"O\u2019Brien\u00a0AJ, Fullerton\u00a0JN, Massey\u00a0KA, et\u00a0al. Immunosuppression in acutely decompensated cirrhosis is mediated by prostaglandin E2. Nat Med. 2014;20:518\u201323.","journal-title":"Nat Med"},{"key":"1769_CR74","doi-asserted-by":"crossref","first-page":"5465","DOI":"10.1016\/j.bbagen.2013.04.036","volume":"1830","author":"M Anraku","year":"2013","unstructured":"Anraku\u00a0M, Chuang\u00a0VTG, Maruyama\u00a0T, Otagiri\u00a0M. Redox properties of serum albumin. Biochim Biophys Acta. 2013;1830:5465\u201372.","journal-title":"Biochim Biophys Acta"}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-020-01769-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00508-020-01769-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-020-01769-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T10:46:02Z","timestamp":1620816362000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00508-020-01769-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,3]]},"references-count":74,"journal-issue":{"issue":"9-10","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["1769"],"URL":"https:\/\/doi.org\/10.1007\/s00508-020-01769-9","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"value":"0043-5325","type":"print"},{"value":"1613-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,3]]},"assertion":[{"value":"4 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"N.\u00a0Pfisterer received travel support from Abbvie and MSD. M.\u00a0Mandorfer has served as a\u00a0speaker and\/or consultant and\/or advisory board member for AbbVie, Bristol-Myers Squibb, Gilead, Janssen and W.\u00a0L. Gore & Associates and has received a\u00a0research award from Medis. C.\u00a0Schmidbauer received travel support von Gebro, Gilead und Abbvie. M.\u00a0Peck-Radosavljevic has served as a\u00a0speaker for CSL Behring. T.\u00a0Reiberger received travel support from Boehringer-Ingelheim, W.L. Gore & Associates, Gilead, Roche and MSD; grant support from Abbvie, Boehringer-Ingelheim, Gilead, W.L. Gore & Associates, Phenex Pharmaceuticals and Philipps; served on advisory boards for Abbvie, Bayer, Boehringer-Ingelheim, Gilead and MSD; and received lecture fees from Boehringer-Ingelheim, Gore, MSD and Roche. All authors declare that they have no conflicts of interests in regard to this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}